Skip to main content

Table 2 Summary of chromosomal safety of human deciduous pulp stem cell products

From: A model study for the manufacture and validation of clinical-grade deciduous dental pulp stem cells for chronic liver fibrosis treatment

Donor

P3 (in 20 cells)

P10 (in 20 cells)

#1

46, XY (20 cells)

46, XY (20 cells)

#2

46, XX (20 cells)

46, XX (20 cells)

#3

46, XY (20 cells)

N/A

#4

46, XX (20 cells)

46, XX (20 cells)

#5

46, XY (20 cells)

46, XX (20 cells)

#6

46, XX (20 cells)

46, XX (20 cells)

#7

46, XX (20 cells)

46, XX (20 cells)

#8

46, XX (20 cells)

46, XX (17 cells), 46, XX, tas(16;19) (p13.3;q13.4) (3 cells)

#9

46, XY (20 cells)

46, XY (16 cells), 45, XY- (4 cells)

#10

46, XY (20 cells)

46, XY (20 cells)

  1. P3, passage 3 human deciduous pulp stem cell products; P10, passage 10 human deciduous pulp stem cell product. N/A not available
Back to article page